Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Brenner

Showing results (211-220 of 271) with videos related to

Pageof 28
Sort By:
Plastic and Reconstructive Surgery|July 31, 2013
The chemokine stromal cell-derived factor-1α promotes endothelial progenitor cell-mediated neovascularization of human transplanted fat tissue in diabetic immunocompromised miceSaher Hamed, Dana Egozi, Hanna Dawood, et al.
European Journal of Internal Medicine|October 8, 2014
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapyInna Tzoran, Benjamin Brenner, Gleb Sakharov, et al.
Biomedical Optics Express|March 18, 2024
Quantifying nanoscopic alterations associated with mitochondrial dysfunction using three-dimensional single-molecule localization microscopyBenjamin Brenner, Fengyuanshan Xu, Yang Zhang, et al.
Archives of Gynecology and Obstetrics|February 9, 2021
Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal studyJohnny S Younis, Mariana Issawy, Ido Izhaki, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
Pulmonary embolism: Epidemiology and registriesManuel Monreal, Isabelle Mahé, Alessandra Bura-Riviere, et al.
Carcinogenesis|August 14, 2018
Semaphorin-3A inhibits multiple myeloma progression in a mouse modelNoa Lavi, Ofra Kessler, Keren Ziv, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Haematologica|August 12, 2021
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trialCecilia Becattini, Rupert Bauersachs, Giorgio Maraziti, et al.
The American Journal of Medicine|December 18, 2016
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of AnticoagulationInna Tzoran, Manolis Papadakis, Benjamin Brenner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio studyMelina Verso, Giancarlo Agnelli, Andrés Munoz, et al.
Pageof 28

Showing results (211-220 of 271) with videos related to

Sort By:
Pageof 28
Plastic and Reconstructive Surgery|July 31, 2013
The chemokine stromal cell-derived factor-1α promotes endothelial progenitor cell-mediated neovascularization of human transplanted fat tissue in diabetic immunocompromised miceSaher Hamed, Dana Egozi, Hanna Dawood, et al.
European Journal of Internal Medicine|October 8, 2014
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapyInna Tzoran, Benjamin Brenner, Gleb Sakharov, et al.
Biomedical Optics Express|March 18, 2024
Quantifying nanoscopic alterations associated with mitochondrial dysfunction using three-dimensional single-molecule localization microscopyBenjamin Brenner, Fengyuanshan Xu, Yang Zhang, et al.
Archives of Gynecology and Obstetrics|February 9, 2021
Protein C global assay evaluation in naturally conceived vs. assisted reproduction-achieved twin pregnancies: a prospective longitudinal studyJohnny S Younis, Mariana Issawy, Ido Izhaki, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
Pulmonary embolism: Epidemiology and registriesManuel Monreal, Isabelle Mahé, Alessandra Bura-Riviere, et al.
Carcinogenesis|August 14, 2018
Semaphorin-3A inhibits multiple myeloma progression in a mouse modelNoa Lavi, Ofra Kessler, Keren Ziv, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Haematologica|August 12, 2021
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trialCecilia Becattini, Rupert Bauersachs, Giorgio Maraziti, et al.
The American Journal of Medicine|December 18, 2016
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of AnticoagulationInna Tzoran, Manolis Papadakis, Benjamin Brenner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2022
Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio studyMelina Verso, Giancarlo Agnelli, Andrés Munoz, et al.
Pageof 28